4D Molecular Therapeutics, Inc.
FDMTNASDAQHealthcare● Active
$8.64
+$0.00(+0.00%)
Market Cap$451666835
P/E Ratio—
52W High$12.34
52W Low$3.68
4D Molecular Therapeutics, Inc.（FDMT）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · FDMT · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $402.65M | $424.88M | $288.23M | $213.55M | $247.78M |
| Net Receivables | $0.00M | $0.00M | $0.00M | $0.70M | $0.05M |
| Inventory | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Current Assets | $413.13M | $434.93M | $296.59M | $220.51M | $256.28M |
| PP&E Net | $33.01M | $40.61M | $31.66M | $35.35M | $28.95M |
| Goodwill | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Intangible Assets | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Assets | $566.71M | $560.38M | $339.89M | $261.85M | $353.49M |
| Liabilities | |||||
| Short-Term Debt | $5.59M | $0.00M | $0.00M | $2.65M | $0.00M |
| Accounts Payable | $11.16M | $4.39M | $3.52M | $3.32M | $4.76M |
| Total Current Liabilities | $43.98M | $29.15M | $18.95M | $15.73M | $16.34M |
| Long-Term Debt | $15.82M | $0.00M | $0.00M | $0.00M | $0.00M |
| Total Liabilities | $61.05M | $49.78M | $32.06M | $30.51M | $34.38M |
| Stockholders Equity | |||||
| Retained Earnings | ($716.30M) | ($576.20M) | ($415.33M) | ($314.49M) | ($207.00M) |
| Total Stockholders Equity | $505.66M | $510.61M | $307.83M | $231.34M | $319.11M |
| Total Liab & Equity(computed) | $566.71M | $560.38M | $339.89M | $261.85M | $353.49M |
| Debt Summary | |||||
| Total Debt | $21.41M | $24.61M | $14.67M | $16.12M | $16.45M |
| Net Debt | ($38.83M) | ($124.73M) | ($234.44M) | ($36.23M) | ($136.55M) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解4D Molecular Therapeutics, Inc.
关于4D Molecular Therapeutics, Inc.（FDMT）资产负债表
4D Molecular Therapeutics, Inc.总资产$0.57B，现金及短期投资$0.40B，总负债$0.06B，总债务$0.02B，股东权益$0.51B。
常见问题
FDMT · 4 问4D Molecular Therapeutics, Inc.总债务$0.02B，净债务($0.04B)。
FDMT total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10